AstraZeneca PLC (AZN.L) Profit Metrics
Price: $11316.00
Market Cap: $175.47B
Avg Volume: 2.74M
Market Cap: $175.47B
Avg Volume: 2.74M
Country: GB
Industry: Drug Manufacturers - General
Sector: Healthcare
Industry: Drug Manufacturers - General
Sector: Healthcare
Profit Metrics Summary (Annual)
According to AstraZeneca PLC's latest annual financial reports:
- The company has reported a gross profit of 43.87B, indicating the amount earned after deducting the cost of goods sold (COGS) from revenue. The gross profit margin is 81.12%, with a year-over-year growth of 16.14%.
- AstraZeneca PLC's EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) is 17.12B. The EBITDA margin stands at 31.66%, showing a growth of 23.07% compared to the previous year.
- The operating income, representing the profit from business operations before taxes and interest, stands at 10.00B. The operating margin is 18.50%, with a year-over-year growth of 22.09%.
- The net income, which shows the company's total earnings or profit after all expenses, is 7.04B. The net profit margin is 13.01%, demonstrating a growth of 18.14% from the previous year.
These metrics provide a comprehensive overview of AstraZeneca PLC's profitability and operational efficiency over the past year.
Gross Profit
$43.87B
Gross Profit Margin (2023)
81.12%
EBITDA
$17.12B
EBITDA Margin
31.66%
Operating Income (2023)
$10.00B
Operating Margin
18.50%
Net Income
$7.04B
Net Profit Margin
13.01%
Historical Gross Profit
Historical Gross Profit Margin
Historical Gross Profit Growth
Historical EBITDA
Historical EBITDA Margin
Historical EBITDA Growth
Historical Operating Income
Historical Operating Profit Margin
Historical Operating Income Growth
Historical Net Income
Historical Net Profit Margin
Historical Net Income Growth
AstraZeneca PLC Historical Profit Metrics
AstraZeneca PLC Historical Profits
The table below shows various profit metrics for each year, with the latest data available for the last fiscal year 2024.
| Year | Gross Profit | Gross Profit Growth | Operating Income | Operating Income Growth | Net Income | Net Income Growth | EBITDA | EBITDA Growth |
|---|---|---|---|---|---|---|---|---|
| 2024 | $43.87B | 16.14% | $10.00B | 22.09% | $7.04B | 18.14% | $17.12B | 23.07% |
| 2023 | $37.77B | 18.18% | $8.19B | 118.07% | $5.96B | 81.11% | $13.91B | 53.13% |
| 2022 | $31.96B | 27.94% | $3.76B | 255.78% | $3.29B | 2835.71% | $9.09B | 77.68% |
| 2021 | $24.98B | 17.18% | $1.06B | -79.54% | $112.00M | -96.50% | $5.11B | -36.75% |
| 2020 | $21.32B | 9.53% | $5.16B | 76.54% | $3.20B | 139.40% | $8.08B | 20.44% |
| 2019 | $19.46B | 13.46% | $2.92B | -13.67% | $1.33B | -38.05% | $6.71B | -5.62% |
| 2018 | $17.15B | -5.47% | $3.39B | -7.89% | $2.15B | -28.19% | $7.11B | 7.38% |
| 2017 | $18.15B | -3.86% | $3.68B | -24.99% | $3.00B | -14.23% | $6.62B | -8.97% |
| 2016 | $18.88B | -5.91% | $4.90B | 19.15% | $3.50B | 23.86% | $7.28B | 4.54% |
| 2015 | $20.06B | -0.94% | $4.11B | 92.51% | $2.83B | 129.12% | $6.96B | 26.75% |
| 2014 | $20.25B | -0.96% | $2.14B | -42.43% | $1.23B | -51.76% | $5.49B | -34.18% |
| 2013 | $20.45B | -9.43% | $3.71B | -54.44% | $2.56B | -59.41% | $8.34B | -21.91% |
| 2012 | $22.58B | -18.08% | $8.15B | -36.32% | $6.30B | -36.92% | $10.68B | -30.57% |
| 2011 | $27.57B | 2.55% | $12.79B | 11.32% | $9.98B | 23.97% | $15.39B | 4.39% |
| 2010 | $26.88B | -0.55% | $11.49B | -0.42% | $8.05B | 7.07% | $14.74B | 5.69% |
| 2009 | $27.03B | 8.10% | $11.54B | 26.24% | $7.52B | 23.27% | $13.95B | 10.53% |
| 2008 | $25.00B | 6.15% | $9.14B | 12.97% | $6.10B | 9.04% | $12.62B | 26.81% |
| 2007 | $23.55B | 12.62% | $8.09B | -1.48% | $5.59B | -7.41% | $9.95B | 4.07% |
| 2006 | $20.92B | 12.49% | $8.22B | 26.36% | $6.04B | 28.41% | $9.56B | 22.12% |
| 2005 | $18.59B | 14.54% | $6.50B | 43.00% | $4.71B | 28.44% | $7.83B | 34.63% |
Related Metrics
Explore detailed financial metrics and analysis for AZN.L.